Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
2,995.9
-

 

  • STI Straits Times Index
    2,995.9
    -
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,601.9
    -7.6 (-0.47%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    29,642.3
    -
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,566.4
    -
    Index delayed 15 minutes
  • N225 Nikkei 225
    28,625.1
    -8.4 (-0.03%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    6,321.9
    -
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 2,649.3M
  • Value: 1,364.1M
  • Rise: 204
  • Fall: 132
  • Unch: 443

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Frasers L&C Tr1.570-
3Cnergy0.015-
8Telecom0.069-
A-Smart0.240-
A-Sonic Aero^0.340-
ABF SG BOND ETF1.230-
ABR0.600-
ACH ADR US$13.290-
AEI^1.060-
AEM4.010-

World Indices

World Indices
Name Last Change
Nasdaq 12,998.5 -114.1
HSI 29,642.3
HSCEI 11,734.3
Jakarta 6,321.9
Nikkei 225 28,656.0 +22.5
SSE Comp 3,566.4
Shanghai A 3,738.3
Shanghai B 250.1
KOSPI 3,121.1 +28.5

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

ALKERMES PLC ALKERMES PLC
Updated on 15 Jan 2021 (End of trading day)
Last (USD): 22.370 Change: +0.370 High: 22.460 Remarks: -
Change (%): +1.68 Low: 21.460
Open 21.900 Yesterday's Close 22.0
Buy Price - Sell Price -
Buy Volume (share) - Sell Volume (share) -
Cumulative Volume (share) 2,026,181 Cumulative Value
Click to show Stock Prices chart

Key Statistics

EPS (USD) a -1.23544 Trailing EPS (USD) e -0.46229 NAV (USD) b 6.8134
PE a - Trailing PE f - Price / NAV b 3.2832
Dividend (USD) d - Cash In Hand (USD) g 1.5135 Issued & Paid-up Shares c 159,150,000
Dividend Yield (%) d - Price / Cash In Hand g 14.780 Treasury Shares h 3,102,712
Market Cap (M) 3,560.186 Enterprise Value (M) 3,376.401
Piotroski F Score 4 Exchange Code ALKS Par Value ( $ ) n.a.
52 Weeks Volatility (%) 53.42 Free Float (%) -
Sector & Industry Health Technology - Biotechnology
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 30 Oct 2020.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 30 Oct 2020.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference ALKERMES PLC NASDAQ 3,560.186 - - 3.2832 -
Industry Biotechnology NASDAQ 3,148.275 491.448 - 7.5529 0.541
Local Peer AMGEN INC NASDAQ 142,916.668 18.225 19.439 13.0411 2.400
Local Peer GILEAD SCIENCES INC NASDAQ 79,386.055 14.739 62.607 4.5506 4.019
Local Peer VERTEX PHARMACEUTICAL NASDAQ 58,651.571 49.839 21.798 7.2111 -
Local Peer REGENERON PHARMACEUTICALS INC NASDAQ 55,266.223 26.121 17.511 5.4581 -
Local Peer ILLUMINA INC NASDAQ 54,947.100 54.837 86.124 11.6909 -
Local Peer MODERNA INC NASDAQ 51,303.802 - - 18.5897 -
Local Peer BIOGEN INC NASDAQ 42,446.811 7.208 8.352 3.9454 -
Local Peer ALEXION PHARMACEUTICAL INC NASDAQ 34,273.581 14.255 35.829 3.0947 -
Local Peer SEAGEN INC NASDAQ 33,491.840 - 70.896 14.8324 -
Local Peer BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS NASDAQ 31,460.377 - - 7.3377 -
Local Peer BIONTECH SE SPON ADS EACH REP 1 ORD SHS NASDAQ 24,195.995 - - 22.2419 -
Local Peer EXACT SCIENCES CORP NASDAQ 23,213.609 - - 9.9326 -
Other Local Peers INCYTE CORPORATION (NASDAQ), 10X GENOMICS INC (NASDAQ), ALNYLAM PHARMACEUTICALS INC (NASDAQ), BIOMARIN PHARMACEUTICAL (NASDAQ), ZAI LAB LIMITED ADS EACH REP 1 ORD SHS (NASDAQ), CRISPR THERAPEUTICS AG (NASDAQ), BIO-TECHNE CORP (NASDAQ), ABCELLERA BIOLOGICS INC (NASDAQ), MIRATI THERAPEUTICS INC (NASDAQ), FATE THERAPEUTICS (NASDAQ), NEUROCRINE BIOSCIENCES INC (NASDAQ), ULTRAGENYX PHARMACEUTICAL INC (NASDAQ), TWIST BIOSCIENCE CORPORATION (NASDAQ), DENALI THERAPEUTICS INC (NASDAQ), IONIS PHARMACEUTICALS INC (NASDAQ), ACADIA PHARMACEUTICALS INC (NASDAQ), BRIDGEBIO PHARMA INC (NASDAQ), ARROWHEAD PHARMACEUTICALS INC (NASDAQ), NOVAVAX INC (NASDAQ), KODIAK SCIENCES INC (NASDAQ), ACCELERON PHARMA (NASDAQ), IOVANCE BIOTHERAPEUTICS INC (NASDAQ), EXELIXIS INC (NASDAQ), SAREPTA THERAPEUTICS INC (NASDAQ), PACIFIC BIOSCIENCES CALIFORNIA INC (NASDAQ), TG THERAPEUTICS INC (NASDAQ), GALAPAGOS NV SPON ADR REPR 1 ORD SHS (NASDAQ), BEAM THERAPEUTICS INC (NASDAQ), HALOZYME THERAPEUTICS INC (NASDAQ), AMICUS THERAPEUTICS INC (NASDAQ), BLUEPRINT MEDICINES CORP (NASDAQ), ABCAM PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), VIR BIOTECHNOLOGY INC (NASDAQ), EIDOS THERAPEUTICS INC (NASDAQ), INTELLIA THERAPEUTICS INC (NASDAQ), EDITAS MEDICINE INC (NASDAQ), SEER INC (NASDAQ), ARENA PHARMACEUTICALS INC (NASDAQ), PTC THERAPEUTICS INC (NASDAQ), CHINA BIOLOGIC PRODUCTS HLDGS INC (NASDAQ), ALLOGENE THERAPEUTICS INC (NASDAQ), IMMUNOVANT INC (NASDAQ), ARVINAS INC (NASDAQ), CHEMOCENTRYX INC (NASDAQ), RELAY THERAPEUTICS INC (NASDAQ), FIBROGEN INC (NASDAQ), INSMED INC (NASDAQ), MORPHOSYS SPON ADS EACH REP 0.25 ORD SHS (NASDAQ), KYMERA THERAPEUTICS INC (NASDAQ), PRELUDE THERAPEUTICS INC (NASDAQ), BLUEBIRD BIO INC (NASDAQ), ROCKET PHARMACEUTICALS INC (NASDAQ), AGIOS PHARMACEUTICALS INC (NASDAQ), NANOSTRING TECHNOLOGIES INC (NASDAQ), GLOBAL BLOOD THERAPEUTICS INC (NASDAQ), VERACYTE INC (NASDAQ), ALLOVIR INC (NASDAQ), DECIPHERA PHARMACEUTICALS INC (NASDAQ), XENCOR INC (NASDAQ), INTRA-CELLUAR THERAPIES INC (NASDAQ), SORRENTO THERAPEUTICS INC (NASDAQ), STOKE THERAPEUTICS INC (NASDAQ), SERES THERAPEUTICS (NASDAQ), SANGAMO THERAPEUTICS INC (NASDAQ), KURA ONCOLOGY INC (NASDAQ), REGENXBIO INC (NASDAQ), NGM BIOPHARMACEUTICALS INC (NASDAQ), MYRIAD GENETICS INC (NASDAQ), ZENTALIS PHARMACEUTICALS INC (NASDAQ), REPLIMUNE GROUP INC (NASDAQ), LIGAND PHARMACEUTICAL INC (NASDAQ), VIELA BIO INC (NASDAQ), SCHOLAR ROCK HOLDING CORPORATION (NASDAQ), SHATTUCK LABS INC (NASDAQ), NANTKWEST INC (NASDAQ), DICERNA PHARMACEUTICALS INC. (NASDAQ), TRANSLATE BIO INC (NASDAQ), PERSONALIS INC (NASDAQ), AURINIA PHARMACEUTICALS INC (NASDAQ), NKARTA INC (NASDAQ), UNIQURE N.V. (NASDAQ), C4 THERAPEUTICS INC (NASDAQ), HERON THERAPEUTICS INC (NASDAQ), GRACELL BIOTECHNOLOGIES INC SPON ADS EACH REP 5 ORD SHS (NASDAQ), BIONANO GENOMICS INC (NASDAQ), PURETECH HEALTH PLC SPON ADS EACH REP 10 ORD SHS (NASDAQ), BIOCRYST PHARMACEUTICALS INC (NASDAQ), ATARA BIOTHERAPEUTICS INC (NASDAQ), BIOATLA INC (NASDAQ), COMPASS PATHWAYS PLC UNSPON ADS REP 1 ORD SHS (NASDAQ), RHYTHM PHARMACEUTICALS INC (NASDAQ), TRILLIUM THERAPEUTICS INC (NASDAQ), MERSANA THERAPEUTICS INC (NASDAQ), PRECIGEN INC (NASDAQ), TRAVERE THERAPEUTICS INC (NASDAQ), IMMUNOGEN INC (NASDAQ), CYTOKINETICS INC (NASDAQ), ALECTOR INC (NASDAQ), CELLECTIS ADS EACH REPR 1 ORD SPON (NASDAQ), VAXCYTE INC (NASDAQ), DYNE THERAPEUTICS INC (NASDAQ), PASSAGE BIO INC (NASDAQ), LUMINEX CORP(DEL) (NASDAQ), COHERUS BIOSCIENCES INC (NASDAQ), INHIBRX INC (NASDAQ), BIOXCEL THERAPEUTICS INC (NASDAQ), ITEOS THERAPEUTICS INC (NASDAQ), APPLIED MOLECULAR TRANSPORT INC (NASDAQ), 4D MOLECULAR THERAPEUTICS INC (NASDAQ), FREQUENCY THERAPEUTICS INC (NASDAQ), EPIZYME INC (NASDAQ), MACROGENICS INC (NASDAQ), BENITEC BIOPHARMA INC (NASDAQ), MESOBLAST LTD SPON ADR EACH REP 5 SHS (NASDAQ), TAYSHA GENE THERAPIES INC (NASDAQ), OMEROS CORP (NASDAQ), ADVERUM BIOTECHNOLOGIES INC (NASDAQ), KARYOPHARM THERAPEUTICS INC (NASDAQ), SYNDAX PHARMACEUTICALS INC (NASDAQ), CURIS INC (NASDAQ), COMPUGEN (NASDAQ), SIGILON THERAPEUTICS INC (NASDAQ), PROTAGONIST THERAPEUTICS INC (NASDAQ), RADIUS HEALTH INC (NASDAQ), AVIDITY BIOSCIENCES INC (NASDAQ), MIMEDX GROUP INC (NASDAQ), LEXICON PHARMACEUTICALS INC (NASDAQ), BLACK DIAMOND THERAPEUTICS INC (NASDAQ), CORTEXYME INC (NASDAQ), HUMANIGEN INC (NASDAQ), MORPHIC HOLDING INC (NASDAQ), ENANTA PHARMACEUTICALS INC (NASDAQ), MERIDIAN BIOSCIENCE INC COM (NASDAQ), PLIANT THERAPEUTICS INC (NASDAQ), CARA THERAPEUTICS INC (NASDAQ), ADAPTIMMUNE THERAPEUTICS PLC SPON ADS EACH REP 6 ORD SHS (NASDAQ), ATHIRA PHARMA INC (NASDAQ), KADMON HLDGS INC (NASDAQ), AVID BIOSERVICES INC (NASDAQ), SYROS PHARMACEUTICALS INC (NASDAQ), AFFIMED N V (NASDAQ), VAXART INC (NASDAQ), PREVAIL THERAPEUTICS INC (NASDAQ), VBI VACCINES INC CDA (NASDAQ), COGENT BIOSCIENCES INC (NASDAQ), RUBIUS THERAPEUTICS INC (NASDAQ), HARPOON THERAPEUTICS INC (NASDAQ), ZIOPHARM ONCOLOGY INC (NASDAQ), VANDA PHARMACE INC (NASDAQ), MANNKIND CORPORATION (NASDAQ), IMMATICS N V (NASDAQ), ANAPTYSBIO INC (NASDAQ), ESPERION THERAPEUTICS INC (NASDAQ), MEIRAGTX HOLDINGS PLC (NASDAQ), FOGHORN THERAPEUTICS INC (NASDAQ), MERUS B V (NASDAQ), FIVE PRIME THERAPEUTICS (NASDAQ), ONCORUS INC (NASDAQ), ASPIRA WOMENS HEALTH INC (NASDAQ), FLEXION THERAPEUTICS INC (NASDAQ), AGENUS INC (NASDAQ), RIGEL PHARMACEUTICALS INC (NASDAQ), DBV TECHNOLOGIES SPON ADR EACH REPR 0.5 ORD (NASDAQ), ARDELYX INC (NASDAQ), FREELINE THERAPEUTICS HLDGS PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), AKOUOS INC (NASDAQ), ALDEYRA THERAPEUTICS (NASDAQ), INVENTIVA SA SPON ADS EACH REP 1 ORD SHS (NASDAQ), AVROBIO INC (NASDAQ), AQUABOUNTY TECHNOLOGIES INC (NASDAQ), PRECISION BIOSCIENCES INC (NASDAQ), HOMOLOGY MEDICINES INC (NASDAQ), BICYCLE THERAPEUTICS PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), DYNAVAX TECHNOLOGIES CORP (NASDAQ), PANDION THERAPEUTICS INC (NASDAQ), XENON PHARMACEUTICALS INC (NASDAQ), NEOLEUKIN THERAPEUTICS INC (NASDAQ), ATRECA INC (NASDAQ), MOLECULAR TEMPLATES INC (NASDAQ), SOLID BIOSCIENCES INC (NASDAQ), SPRUCE BIOSCIENCES INC (NASDAQ), PROTHENA CORP PLC (NASDAQ), POSEIDA THERAPETUICS INC (NASDAQ), BIOVIE INC (NASDAQ), SPECTRUM PHARMACEUTICALS INC (NASDAQ), OPTHEA LIMITED SPON ADS EACH REPR 8 ORD SHS (NASDAQ), RAPT THERAPEUTICS INC (NASDAQ), GERON CORP (NASDAQ), IVERIC BIO INC (NASDAQ), FORTE BIOSCIENCES INC (NASDAQ), SURFACE ONCOLOGY INC (NASDAQ), CHIMERIX INC (NASDAQ), CLOVIS ONCOLOGY INC (NASDAQ), XBIOTECH INC (NASDAQ), VIKING THERAPEUTICS INC (NASDAQ), AUTOLUS THERAPEUTICS PLC SPON ADS EA REP 1 ORD SHS (NASDAQ), SINOVAC BIOTECH LTD (NASDAQ), GREENWICH LIFESCIENCES INC (NASDAQ), WAVE LIFE SCIENCES LTD (NASDAQ), UROGEN PHARMA LTD (NASDAQ), AKEBIA THERAPEUTICS INC (NASDAQ), XOMA CORP (NASDAQ), SUMMIT THERAPEUTICS INC (NASDAQ), PUMA BIOTECHNOLOGY INC (NASDAQ), CASI PHARMACEUTICALS INC (NASDAQ), CYMABAY THERAPEUTICS INC (NASDAQ), VERASTEM INC (NASDAQ), MAGENTA THERAPEUTICS INC (NASDAQ), APTOSE BIOSCIENCES INC (NASDAQ), ANAVEX LIFE SCIENCES CORPORATION (NASDAQ), SELECTA BIOSCIENCES INC (NASDAQ), AEGLEA BIOTHERAPEUTICS INC (NASDAQ), CUE BIOPHARMA INC (NASDAQ), ATHERSYS INC (NASDAQ), CYTOMX THERAPEUTICS INC (NASDAQ), UNITY BIOTECHNOLOGY INC (NASDAQ), JOUNCE THERAPEUTICS INC (NASDAQ), CONCERT PHARMACEUTICALS INC (NASDAQ), OCUGEN INC (NASDAQ), EIGER BIOPHARMACEUTICALS INC (NASDAQ), INNATE PHARMA SPON ADS EACH REP 1 ORD SHS (NASDAQ), NUCANA PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), CELLULAR BIOMEDICINE GROUP INC (NASDAQ), NEXTCURE INC (NASDAQ), INMUNE BIO INC (NASDAQ), TREVENA INC (NASDAQ), VISTAGEN THERAPEUTICS INC (NASDAQ), ARBUTUS BIOPHARMA CORP (NASDAQ), VOYAGER THERAPEUTICS INC (NASDAQ), FORTRESS BIOTECH INC (NASDAQ), CABALETTA BIO INC (NASDAQ), ALPINE IMMUNE SCIENCES INC (NASDAQ), KAMADA LTD (NASDAQ), PARATEK PHARMACEUTICALS INC (NASDAQ), LARIMAR THERAPEUTICS INC (NASDAQ), CO DIAGNOSTICS INC (NASDAQ), TIZIANA LIFE SCIENCES PLC SPON ADS EACH REPR 10 ORD SHS (NASDAQ), BELLUS HEALTH INC (NASDAQ), CHECKMATE PHARMACEUTICALS INC (NASDAQ), 9 METERS BIOPHARMA INC (NASDAQ), T2 BIOSYSTEMS INC (NASDAQ), NEPTUNE WELLNESS SOLUTIONS INC (NASDAQ), ADICET BIO INC (NASDAQ), MEDICINOVA INC (NASDAQ), KEZAR LIFE SCIENCES INC (NASDAQ), OTONOMY INC (NASDAQ), IMMUNOPRECISE ANTIBODIES LTD (NASDAQ), IMV INC (NASDAQ), AVEO PHARMACEUTICALS INC (NASDAQ), CALITHERA BIOSCIENCES INC (NASDAQ), METACRINE INC (NASDAQ), CHIASMA INC (NASDAQ), MEREO BIOPHARMA GROUP PLC SPON ADS EACH REP 5 ORD SHS (NASDAQ), EVOGENE LTD (NASDAQ), EVOFEM BIOSCIENCES INC (NASDAQ), PROQR THERAPEUTICS N V (NASDAQ), ERYTECH PHARMA SPON ADR EACH REPR 1 ORD (NASDAQ), AXCELLA HEALTH INC (NASDAQ), GENFIT SPON ADS EACH REP 1 ORD SHS (NASDAQ), PLURISTEM THERAPEUTICS INC (NASDAQ), INFINITY PHARMACEUTICALS INC (NASDAQ), MEDICENNA THERAPEUTICS CORP (NASDAQ), SESEN BIO INC (NASDAQ), BIOFRONTERA AG SPON ADS EACH REP TWO ORD SHS (NASDAQ), EDAP TMS S.A. SPON ADR EACH REPR 1 ORD SHARE (NASDAQ), ADMA BIOLOGICS INC (NASDAQ), STRONGBRIDGE BIOPHARMA PLC (NASDAQ), FENNEC PHARMACEUTICALS INC (NASDAQ), DIAMEDICA THERAPEUTICS INC (NASDAQ), TAIWAN LIPOSOME COMPANY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), GLYCOMIMETICS INC (NASDAQ), SIERRA ONCOLOGY INC (NASDAQ), LUMOS PHARMA INC (NASDAQ), ONCONOVA THERAPEUTICS INC (NASDAQ), IMMUTEP LTD SPON ADS EACH REP 10 ORD SHS (NASDAQ), IDERA PHARMACEUTICALS INC (NASDAQ), HARVARD BIOSCIENCE INC (NASDAQ), ELOXX PHARMACEUTICALS INC (NASDAQ), BRAINSTROM CELL THERAPEUTICS (NASDAQ), LIMINAL BIOSCIENCES INC (NASDAQ), OUTLOOK THERAPEUTICS INC (NASDAQ), VTV THERAPEUTICS INC (NASDAQ), AZIYO BIOLOGICS INC (NASDAQ), CHAMPIONS ONCOLOGY INC (NASDAQ), PIERIS PHARMACEUTICALS INC (NASDAQ), LA JOLLA PHARMACEUTICAL CO (NASDAQ), CORBUS PHARMACEUTICALS HOLDINGS IN (NASDAQ), DYADIC INTERNATIONAL INC (NASDAQ), INFLARX N V (NASDAQ), HEAT BIOLOGICS INC (NASDAQ), IMMUNOME INC (NASDAQ), CATALYST BIOSCIENCES INC (NASDAQ), ENOCHIAN BIOSCIENCES INC (NASDAQ), CONTRAFECT CORP (NASDAQ), APTEVO THERAPEUTICS INC (NASDAQ), GENOCEA BIOSCIENCES INC (NASDAQ), TRACON PHARMACEUTICALS INC (NASDAQ), SIO GENE THERAPIES INC (NASDAQ), X4 PHARMACEUTICALS INC (NASDAQ), LEAP THERAPEUTICS INC (NASDAQ), EQUILLIUM INC (NASDAQ), ORGENESIS INC (NASDAQ), GALECTIN THERAPEUTICS INC (NASDAQ), SYNLOGIC INC (NASDAQ), VASCULAR BIOGENICS LTD (NASDAQ), ONCOLYTICS BIOTECH INC (NASDAQ), CELYAD ONCOLOGY SPON ADS EACH REPR 1 ORD SHS (NASDAQ), APPLIED GENETIC TECHNOLOGIES CORP (NASDAQ), ANIXA BIOSCIENCES INC (NASDAQ), MINERVA NEUROSCIENCES INC (NASDAQ), MERRIMACK PHARMACEUTICALS INC (NASDAQ), CIDARA THERAPEUTICS INC (NASDAQ), CAPRICOR THERAPEUTICS INC (NASDAQ), WINDTREE THERAPEUTICS INC (NASDAQ), NEUROBO PHARMACEUTICALS INC (NASDAQ), KAZIA THERAPEUTICS LIMITED SPON ADR EACH REP 10 ORD SHS (NASDAQ), ARAVIVE INC (NASDAQ), ORGANOVO HLDGS INC (NASDAQ), ENTASIS THERAPEUTICS HLDGS INC (NASDAQ), AVALON GLOBOCARE CORP (NASDAQ), CELLECTAR BIOSCIENCES INC (NASDAQ), MIRAGEN THERAPEUTICS INC (NASDAQ), SEELOS THERAPEUTICS INC (NASDAQ), COHBAR INC (NASDAQ), STEALTH BIOTHERAPEUTICS CORP SPON ADS EACH REP 12 ORD SHS (NASDAQ), SAVARA INC (NASDAQ), MONOPAR THERAPEUTICS INC (NASDAQ), ASLAN PHARMACEUTICALS LIMITED ADS EACH REP 5 ORD SHS (NASDAQ), DIFFUSION PHARMACEUTICALS INC (NASDAQ), SELLAS LIFE SCIENCES GROUP INC (NASDAQ), RECRO PHARMA INC (NASDAQ), ACORDA THERAPEUTICS INC (NASDAQ), BIOCARDIA INC (NASDAQ), NABRIVA THERAPEUTICS PLC (NASDAQ), ITERUM THERAPEUTICS PLC (NASDAQ), GENETIC TECHNOLOGIES SPON ADS EA REP 600 ORD SHS(R/S) (NASDAQ), ADVAXIS INC (NASDAQ), MICROBOT MEDICAL INC (NASDAQ), ALTERITY THERAPEUTICS LIMITED SPON ADS EA REPR 60 ORD SHS (NASDAQ), VACCINEX INC (NASDAQ), CATABASIS PHARMACEUTICALS INC (NASDAQ), SUNESIS PHARMACEUTICALS INC (NASDAQ), ANPAC BIO MEDICAL SCIENCE CO LTD SPON ADS EACH REPR 1 ORD SHS CLASS A (NASDAQ), CLEVELAND BIOLABS INC (NASDAQ), FORWARD PHARMA AS SPON ADS EACH REP 14 ORD SHS (NASDAQ), PULMATRIX INCORPORATED (NASDAQ), SOLIGENIX INC (NASDAQ), KIROMIC BIOPHARMA INC (NASDAQ), SONNET BIOTHERAPEUTICS HLDGS INC (NASDAQ), ARCA BIOPHARMA INC (NASDAQ), ATYR PHARMA INC (NASDAQ), PRECIPIO INC (NASDAQ), AETERNA ZENTARIS INC (NASDAQ), CYCLACEL PHARMACEUTICALS INC (NASDAQ), LIXTE BIOTECHNOLOGY HOLDINGS INC (NASDAQ), AIKIDO PHARMA INC (NASDAQ), ALIMERA SCIENCES INC (NASDAQ), OPIANT PHARMACEUTICALS INC (NASDAQ), ENDRA LIFE SCIENCES INC (NASDAQ), ACHIEVE LIFE SCIENCE INC (NASDAQ), AZURRX BIOPHARMA INC (NASDAQ), HTG MOLECULAR DIAGNOSTICS INC (NASDAQ), ADITX THERAPEUTICS INC (NASDAQ), INMED PHARMACEUTICALS INC (NASDAQ), MIDATECH PHARMA PLC SPON ADS EACH REP 5 ORD SHS(R/S) (NASDAQ), HISTOGEN INC (NASDAQ), CYCLO THERAPEUTICS INC (NASDAQ), AURIS MEDICAL HOLDING LTD (NASDAQ), XENETIC BIOSCIENCES INC (NASDAQ), INVIVO THERAPEUTICS HOLDING CORP (NASDAQ), SENECA BIOPHARMA INC (NASDAQ), XTL BIOPHARMACEUTICALS LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), BELLICUM PHARMACEUTICALS (NASDAQ), BIO-PATH HOLDINGS INC (NASDAQ), GEOVAX LABS INC (NASDAQ), PHIO PHARMACEUTICALS CORP (NASDAQ), ANCHIANO THERAPEUTICS LTD SPON ADS EACH REP 5 ORD SHS (NASDAQ), PLUS THERAPEUTICS INC (NASDAQ), CELLECT BIOTECHNOLOGY LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), SENESTECH INC (NASDAQ)
Global Peer CSL LTD ASX 123,361.650 39.333 39.333 13.0120 1.082
Global Peer WUXI BIO HKEx 452,591.408 393.704 314.320 30.2981 -
Global Peer BEIGENE HKEx 256,533.544 - - 7.7204 -
Global Peer SINO BIOPHARM HKEx 138,657.949 45.176 54.184 3.8472 0.724
Global Peer ZAI LAB-SB HKEx 120,857.227 - - 33.5010 -
Global Peer EMERGENT BIOSOLUTIONS INC NYSE 5,633.274 103.363 33.813 4.5012 -
Global Peer Lonza SGX 5,940.891 6.617 5.028 0.6269 4.784
Global Peer GENSCRIPT BIO HKEx 21,657.781 - - 2.9621 -
Global Peer ARCUS BIOSCIENCES INC NYSE 2,400.864 - - 4.4100 -
Global Peer 3SBIO HKEx 18,695.460 16.932 12.451 1.5982 -
Other Global Peers VIVA BIOTECH (HKEx), JACOBIO-B (HKEx), MYOVANT SCIENCES LTD (NYSE), ALPHAMAB-B (HKEx), JW THERAP-B (HKEx), ASCENTAGE-B (HKEx), FRONTAGE (HKEx), POLYNOVO LIMITED (ASX), JHBP-B (HKEx), HAOHAI BIOTEC (HKEx), MESOBLAST LTD (ASX), TELIX PHARMACEUTIC (ASX), SQZ BIOTECHNOLOGIES CO (NYSE), ACTINIUM PHARMACEUTICALS INC (NYSE American), DPHARMA (Bursa), KINTOR PHARMA-B (HKEx), SINOMAB BIO-B (HKEx), OPTHEA LIMITED (ASX), ASCLETIS-B (HKEx), IMUGENE LIMITED (ASX), LEE'S PHARM (HKEx), LINEAGE CELL THERAPEUTICS INC (NYSE American), 22ND CENTURY GROUP INC (NYSE American), ESSEX BIO-TECH (HKEx), IMMUTEP LTD (ASX), NANOVIRICIDES INC (NYSE American), NEXT SCIENCE LTD (ASX), ANTEOTECH LIMITED (ASX), MATINAS BIOPHARMA HOLDINGS INC (NYSE American), ENZO BIOCHEM INC (NYSE), IBIO INC (NYSE American), CEL-SCI CORP (NYSE American), NEUREN PHARMACEUTICALS LTD (ASX), KAZIA THERAPEUTICS LIMITED (ASX), PALATIN TECHNOLOGIES INC (NYSE American), SYNTHETIC BIOLOGICS INC (NYSE American), UNI-BIO GROUP (HKEx), AIM IMMUNOTECH INC (NYSE American), BIONOMICS LTD (ASX), LEAF RESOURCES LTD (ASX), CYNATA THERAPEUTICS LTD (ASX), REGENT PACIFIC (HKEx), ARMATA PHARMACEUTICALS INC (NYSE American), MEMPHASYS LTD (ASX), GENETIC TECHNOLOGIES (ASX), ALTERITY THERAPEUTICS LIMITED (ASX), INVEX THERAPEUTICS LTD NPV (ASX), INDIA GLOBALIZATION CAPITAL INC (NYSE American), ORAGENICS INC (NYSE American), BIOTRON (ASX), CT ENTERPRISE (HKEx), PRESCIENT THERAPEUTICS LIMITED (ASX), PATRYS LIMITED (ASX), CONSTELLATION TECHNOLOGIES LTD (ASX), Suntar Eco-City (SGX), CONTANGO ASSET MANAGEMENT LIMITED (ASX), AVECHO BIOTECHNOLOGY LTD (ASX), CAN FITE BIOPHARMA LTD SPON ADS EA REP 30 ORD SHS(POST REV SPL (NYSE American), REGENEUS LTD (ASX), RHINOMED LIMITED (ASX), ADALTA LTD (ASX), AMPLIA THERAPEUTICS LTD (ASX), AUSTRALIAN PRIMARY HEMP LTD (ASX), ACTINOGEN MEDICAL LTD (ASX), NEUROSCIENTIFIC BIOPHARMA LTD (ASX), CRYOSITE (ASX), HOLISTA COLLTECH LIMITED (ASX), NOVABAY PHARMACEUTICALS INC (NYSE American), NANOLLOSE LTD (ASX), ANATARA LIFESCIENCES LTD (ASX), LIVING CELL TECHNOLOGIES (ASX), HAO WEN HLDGS (HKEx), FACTOR THERAPEUTICS LIMITED (ASX)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days -+0.280
+1.27 %
10 Days -+2.870
+14.72 %
20 Days -+0.890
+4.14 %
Medium Term Return 3 Months -+5.450
+32.21 %
6 Months -+2.950
+15.19 %
1 Year -+3.845
+20.76 %
Long Term Return 2 Years --10.680
-32.31 %
3 Years --36.820
-62.21 %
5 Years --12.390
-35.64 %
Annualised Return Annualised --
-8.44 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 11.980 - 22.545 Change From 1 Year Low +10.390 % Change From 1 Year Low (%) +86.73
Change From 1 Year High -0.175 % Change From 1 Year High (%) -0.78
2 Years Range 11.980 - 37.750 Change From 2 Years Low +10.390 % Change From 2 Years Low (%) +86.73
Change From 2 Years High -15.380 % Change From 2 Years High (%) -40.74
5 Years Range 11.980 - 71.220 Change From 5 Years Low +10.390 % Change From 5 Years Low (%) +86.73
Change From 5 Years High -48.850 % Change From 5 Years High (%) -68.59
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

Alkermes Plc is a biopharmaceutical company, which engages in the development, research, and commercialization of medicines that are designed to address unmet medical needs of patients in major therapeutic areas. Its products include Aristada, which is used for the treatment of schizophrenia in adults; and Vivitrol, which is an injectable medication for the treatment of alcohol dependence and for the prevention of relapse to opioid dependence, following opioid detoxification. The company was founded on May 4, 2011 and is headquartered in Dublin, Ireland.

Historical Price Data

Date Open High Low Close Volume VWAP
15 Jan 2021 21.900 22.460 21.460 22.370 2,026,181 -
14 Jan 2021 21.840 22.075 21.240 22.000 1,006,631 -
13 Jan 2021 22.210 22.330 21.780 21.820 891,571 -
12 Jan 2021 21.390 22.545 21.280 22.090 1,832,791 -
11 Jan 2021 20.380 21.550 20.105 21.460 1,323,793 -
08 Jan 2021 20.460 20.900 19.780 20.380 1,584,210 -
07 Jan 2021 19.810 21.110 19.580 20.585 3,341,206 -
06 Jan 2021 19.320 19.720 19.200 19.500 1,106,796 -
05 Jan 2021 19.620 19.875 19.290 19.500 1,083,248 -
04 Jan 2021 19.930 20.150 19.600 19.740 1,038,745 -
31 Dec 2020 20.500 20.550 19.780 19.950 1,093,812 -
30 Dec 2020 20.670 20.970 20.190 20.450 1,054,582 -
29 Dec 2020 21.970 22.000 20.630 20.760 1,394,895 -
28 Dec 2020 21.800 22.000 21.190 21.250 929,154 -
24 Dec 2020 21.240 21.570 21.160 21.460 907,659 -
23 Dec 2020 21.625 21.625 21.130 21.260 1,139,144 -
22 Dec 2020 21.950 22.190 21.480 21.480 1,031,512 -
21 Dec 2020 21.870 22.090 21.464 21.800 1,307,475 -
18 Dec 2020 21.660 22.000 21.520 22.000 2,216,419 -
17 Dec 2020 21.280 21.700 21.120 21.670 623,838 -
16 Dec 2020 22.220 22.220 21.400 21.500 1,251,683 -
15 Dec 2020 21.990 22.180 21.820 22.100 1,334,299 -
Summary
Current 2 Weeks
(04 Jan 2021 to 15 Jan 2021)
19.930 22.545 19.200 22.370 15,235,172 -
Previous 2 Weeks
(17 Dec 2020 to 31 Dec 2020)
21.280 22.545 19.200 19.950 11,698,490 -
4 Weeks from
(18 Nov 2020 to 16 Dec 2020)
18.760 22.545 17.950 21.500 23,938,024 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.
We use Cookies. By continuing to use this webite, you will be agreeing to our Privacy Policy, Terms and Conditions and Cookie Policy.